By AdminM
by Brian Shilhavy
Editor, Health Impact News
Gardasil vaccine manufacturer, Merck, announced earlier this month (June, 2018) that the U.S. Food and Drug Administration (FDA) has granted them a “Priority Review” to approve the dangerous and controversial Gardasil 9 vaccine to women and men, ages 27 to 45.
The Gardasil vaccine is currently approved for girls and boys, ages 9 through 26.
The request by Merck to expand its market to women and men, ages 27 to 45, and the FDA’s approval to grant it a Priority Review by October 6, 2018, follows 10 years after the FDA struck down …read more
Source: Health Impact News
- Rating:
- Views:366 views
- Categories: Health
Thanks! Share it with your friends!
Tweet
Share
Pin It
LinkedIn
Google+
Reddit
Tumblr